ID: ALA320772

Max Phase: Preclinical

Molecular Formula: C48H50N4O8Si2

Molecular Weight: 867.12

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccc(CCc3ccc4nc5c(c([Si](C)(C)C)c4c3)Cn3c-5cc4c(c3=O)COC(=O)[C@]4(O)CC)cc1c2[Si](C)(C)C

Standard InChI:  InChI=1S/C48H50N4O8Si2/c1-9-47(57)33-19-37-39-29(21-51(37)43(53)31(33)23-59-45(47)55)41(61(3,4)5)27-17-25(13-15-35(27)49-39)11-12-26-14-16-36-28(18-26)42(62(6,7)8)30-22-52-38(40(30)50-36)20-34-32(44(52)54)24-60-46(56)48(34,58)10-2/h13-20,57-58H,9-12,21-24H2,1-8H3/t47-,48-/m0/s1

Standard InChI Key:  SARKWEQVAABQBC-CRKOEVGVSA-N

Associated Targets(Human)

HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
833K (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

DC3F (23 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 867.12Molecular Weight (Monoisotopic): 866.3167AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Josien H, Bom D, Curran DP, Zheng Y, Chou T.  (1997)  7-Silylcamptothecins (silatecans): A new family of camptothecin antitumor agents,  (24): [10.1016/S0960-894X(97)10181-0]

Source